Asthma affects an estimated 262 million people worldwide and caused over 461,000 deaths
in 2019. The disease is characterized by chronic airway inflammation, reversible …

COPD and asthma are important chronic inflammatory disorders with a high associated
morbidity. Much research has concentrated on the role of inflammatory cells, such as the …

Publisher Summary Asthma and chronic obstructive pulmonary disease (COPD) are highly
complex airway-obstruction disease conditions. Chronic inflammation of airways is …

Assessment and management of asthma is complicated by the heterogeneous
pathophysiological mechanisms that underlie its clinical presentation, which are not …

Background Current reviews on the use of inhaled corticosteroids (ICS) for acute asthma
underestimated their early (minutes) clinical impact and produced conclusions of …

Asthma is currently recognized as a chronic inflammatory disorder of the airways that leads
to tissue injury and subsequent structural changes collectively called airway remodeling …

Asthma affects more than 300 million people worldwide and its prevalence is still rising.
Acute asthma attacks are characterized by severe symptoms such as breathlessness …

In chronic lung disorders such as in asthma and chronic obstructive pulmonary disease
(COPD) there is increased bronchial angiogenesis and remodelling of pulmonary vessels …

In asthma there is increased vascularity of the airway mucosa, altering heat loss in the
airways. We hypothesized that as a result of these inflammatory changes, asthmatic patients …

Glucocorticoids are the mainstay of asthma therapy. They are primarily used to suppress
airway inflammation, which is the central pathological change in asthmatic patients' airways …